New Guidelines for Managing Immunotherapy-Related Adverse Events

ONS’s Pamela Ginex, EdD, MPH, RN, OCN®, discusses the new immunotherapy toxicity guidelines released by the National Comprehensive Cancer Network and the American Society of Clinical Oncology. We talk about ONS’s role in helping to develop the information, the importance of educati…

Feb 19^th • 13 mins listen

Why Genetic Testing Should Be Standard in Prostate Cancer

Labcorp, Rebecca Previs, Sarah Young, genetic counselor, genetic testing, prostate cancer, urologic oncology, germline, somatic, PARP inhibitors, digital

Hear why universal genetic testing matters in prostate cancer — plus, how it can improve treatment, equity, and outcomes for patients everywhere.

May 18^th • 19 mins listen